Results: 4

Role of cancer ratio and other new parameters in the differential diagnosis of malignant pleural effusion

Clinics; 76 (), 2021
OBJECTIVES: We compared the diagnostic potential of cancer ratio (CR, serum lactate dehydrogenase [LDH]/pleural fluid adenosine deaminase [pfADA]), cancer ratio plus (CR plus, cancer ratio/pleural lymphocyte percentage), and age/pfADA ratio with pfADA in malignant pleural effusion. METHODS: Data from 10...

Diagnóstico e tratamento dos derrames pleurais malignos

Pulmäo RJ; 25 (1), 2016
Carcinomas brônquicos, com maior frequência os adenocarcinomas, linfomas e carcinoma de mama, constituem 75% das causas de derrame pleural maligno (DPM). Para utilização das diversas opções terapêuticas paliativas disponíveis deve ser considerada uma avaliação multidisciplinar do estado do paci...

Diagnostic value of p16 methylation for malignant pleural effusion a meta-analysis

West Indian med. j; 62 (8), 2013
OBJECTIVE: To evaluate the overall diagnostic performance of the p16 methylation for diagnosing malignant pleural effusion (MPE). METHODS: All published literature in English and Chinese were reviewed. Sensitivity, specificity, likelihood ratio and diagnostic odds ratio (DOR) were pooled by using random-...

Valor de la videotoracoscopia en el derrame pleural maligno
Value of video-assisted throracoscopy in the malignant pleural effusion

Rev. cuba. cir; 47 (3), 2008
La videotoracoscopia es una herramienta útil para el tratamiento de múltiples enfermedades torácicas, entre ellas, del derrame pleural maligno cuando otras modalidades de tratamiento han fallado en el control del derrame. Fue objetivo del presente estudio evaluar en nuestro servicio la utilidad de la ...